Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Welberry Smith

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|January 12, 2008
Assessment and management of a patient with a renal transplantMatthew P Welberry Smith, Richard J Baker
Transplantation|July 1, 2014
The author's replyMatthew P Welberry Smith, Richard J Baker
Nature Reviews. Nephrology|October 28, 2009
Application of proteomic analysis to the study of renal diseasesMatthew P Welberry Smith, Rosamonde E Banks, Steven L Wood, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
Massive aneurysmal dilatation of a depopulated ureteric hemodialysis xenograftMatthew P Welberry Smith, James Ian Spark, Jai V Patel, et al.
Transplantation|January 26, 2010
The clinical significance of early proteinuria after renal transplantationAravind Cherukuri, Matthew P Welberry-Smith, James E Tattersall, et al.
Transplantation|March 19, 2008
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantationMatthew P Welberry Smith, Chas G Newstead, Niaz Ahmad, et al.
Transplantation|September 24, 2013
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trialMatthew P Welberry Smith, Aravind Cherukuri, Chas G Newstead, et al.
Proteomics|May 7, 2011
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesMatthew P Welberry Smith, Steven L Wood, Alexandre Zougman, et al.
Kidney International|June 7, 2013
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantationMatthew P Welberry Smith, Alexandre Zougman, David A Cairns, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Hospital Medicine (London, England : 2005)|January 12, 2008
Assessment and management of a patient with a renal transplantMatthew P Welberry Smith, Richard J Baker
Transplantation|July 1, 2014
The author's replyMatthew P Welberry Smith, Richard J Baker
Nature Reviews. Nephrology|October 28, 2009
Application of proteomic analysis to the study of renal diseasesMatthew P Welberry Smith, Rosamonde E Banks, Steven L Wood, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
Massive aneurysmal dilatation of a depopulated ureteric hemodialysis xenograftMatthew P Welberry Smith, James Ian Spark, Jai V Patel, et al.
Transplantation|January 26, 2010
The clinical significance of early proteinuria after renal transplantationAravind Cherukuri, Matthew P Welberry-Smith, James E Tattersall, et al.
Transplantation|March 19, 2008
Poor tolerance of sirolimus in a steroid avoidance regimen for renal transplantationMatthew P Welberry Smith, Chas G Newstead, Niaz Ahmad, et al.
Transplantation|September 24, 2013
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trialMatthew P Welberry Smith, Aravind Cherukuri, Chas G Newstead, et al.
Proteomics|May 7, 2011
A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesMatthew P Welberry Smith, Steven L Wood, Alexandre Zougman, et al.
Kidney International|June 7, 2013
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantationMatthew P Welberry Smith, Alexandre Zougman, David A Cairns, et al.
Pageof 1